Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism

Frazao, J. M.; Messa, P.; Cunningham, J.; Evenepoel, P.; Shahapuni, I.; Urena, P.; Braun, J.; Zani, V.; Baños, Ana; Molemans, B.; de Francisco, A. L. M.

Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism

Frazao, J. M.

;

Messa, P.

;

Cunningham, J.

;

Evenepoel, P.

;

de Francisco, A. L. M.

;et.al.

(2006) 43rd Annual Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA) — Location: Glasgow(Scotland) (15.July.2006)

Files

No attached file found for this publication.

Details

Authors

Frazao, J. M.
Author
Messa, P.
Author
Cunningham, J.
Author
Evenepoel, P.
Author
de Francisco, A. L. M.
Author

Affiliations

UCLouvainAutre

Citations

APA
Chicago
FWB

Frazao, J. M., Messa, P., Cunningham, J., Evenepoel, P., Shahapuni, I., Urena, P., Braun, J., Zani, V., Baños, A., Molemans, B., & de Francisco, A. L. M. (2006). Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism. Nephrology, Dialysis, Transplantation, 21, 8-9. https://hdl.handle.net/2078.5/139891 (Original work published 2006)